Xeris Pharmaceuticals Inc (XERS)

Jun 3, 2025, 7:30 AM EDT - 2 days ago

Xeris Unveils Strategy for Long-Term Growth and Value Creation at 2025 Analyst & Investor Day

May 20, 2025, 7:30 AM EDT - 16 days ago

Xeris Announces Details for Analyst & Investor Day

May 8, 2025, 2:15 PM EDT - 4 weeks ago

Xeris Biopharma Holdings, Inc. (XERS) Q1 2025 Earnings Call Transcript

May 8, 2025, 7:00 AM EDT - 4 weeks ago

Xeris Biopharma Reports Record First Quarter 2025 Financial Results

May 7, 2025, 11:51 AM EDT - 4 weeks ago

Xeris Biopharma Holdings: Looking For More Growth In Q1 Earnings

May 1, 2025, 7:00 AM EDT - 5 weeks ago

Xeris Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025

Mar 28, 2025, 8:00 AM EDT - 2 months ago

Xeris Announces Changes to Its Board of Directors

Mar 17, 2025, 8:00 AM EDT - 2 months ago

Xeris Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke VialDx™ (glucagon) for Use as a Diagnostic Aid

Mar 6, 2025, 10:52 AM EST - 3 months ago

Xeris Biopharma Holdings, Inc. (XERS) Q4 2024 Earnings Call Transcript

Mar 6, 2025, 7:00 AM EST - 3 months ago

Xeris Biopharma Delivers Record Fourth Quarter and Full-Year 2024 Results; and Announces 2025 Guidance

Feb 27, 2025, 7:00 AM EST - 3 months ago

Xeris Biopharma to Report Fourth Quarter and Full-Year 2024 Financial Results on March 6, 2025

Feb 24, 2025, 8:00 AM EST - 3 months ago

Xeris Appoints Anh Nguyen, MD, MBA as Chief Medical Officer

Feb 5, 2025, 8:00 AM EST - 4 months ago

Xeris to Participate in Upcoming Investor Conferences

Jan 21, 2025, 9:00 AM EST - 4 months ago

The American Diabetes Association and Xeris Pharmaceuticals Announce National Collaboration to Provide Life-Saving Hypoglycemia Education and Awareness

Jan 10, 2025, 7:00 AM EST - 5 months ago

Xeris Expects to Exceed Full-Year 2024 Financial Guidance

Jan 6, 2025, 4:15 PM EST - 5 months ago

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Nov 26, 2024, 7:00 AM EST - 6 months ago

Xeris to Participate in Piper Sandler 36th Annual Healthcare Conference

Nov 8, 2024, 11:50 AM EST - 7 months ago

Xeris Biopharma Holdings, Inc. (XERS) Q3 2024 Earnings Call Transcript

Nov 8, 2024, 7:00 AM EST - 7 months ago

Xeris Biopharma Reports Third Quarter 2024 Financial Results

Oct 31, 2024, 8:00 AM EDT - 7 months ago

Xeris Biopharma to Report Third Quarter 2024 Financial Results on November 8, 2024

Oct 25, 2024, 12:50 PM EDT - 7 months ago

Xeris Biopharma Holdings: Promising Pipeline And Strategic Partnerships Make It Attractive

Oct 11, 2024, 2:00 PM EDT - 8 months ago

Undercovered Dozen: KinderCare Learning, Xeris Biopharma, Generac, Philips +

GNRC KLC PHG

Oct 9, 2024, 11:33 AM EDT - 8 months ago

Xeris Biopharma: Time For A Reassessment

Aug 8, 2024, 11:56 AM EDT - 10 months ago

Xeris Biopharma Holdings, Inc. (XERS) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 7:00 AM EDT - 10 months ago

Xeris Biopharma Reports Second Quarter 2024 Financial Results

Jul 25, 2024, 7:00 AM EDT - 11 months ago

Xeris Biopharma to Report Second Quarter 2024 Financial Results on August 8, 2024

Jul 8, 2024, 7:00 AM EDT - 11 months ago

Xeris Biopharma Announces CEO Succession Plan

Jun 3, 2024, 7:00 AM EDT - 1 year ago

Xeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing's Syndrome Patients at ENDO 2024

May 30, 2024, 7:30 AM EDT - 1 year ago

Xeris Biopharma Announces Positive Topline Phase 2 Clinical Data of Its Investigational XeriSol™-Formulated Once-Weekly Subcutaneous (SC) Levothyroxine (XP-8121)

May 30, 2024, 7:00 AM EDT - 1 year ago

Xeris to Participate in the Jefferies Global Healthcare Conference

May 9, 2024, 12:49 PM EDT - 1 year ago

Xeris Biopharma Holdings, Inc. (XERS) Q1 2024 Earnings Call Transcript

May 9, 2024, 7:00 AM EDT - 1 year ago

Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events

May 6, 2024, 7:00 AM EDT - 1 year ago

Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta Bionics

May 2, 2024, 7:00 AM EDT - 1 year ago

Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024

Apr 3, 2024, 4:05 PM EDT - 1 year ago

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Apr 2, 2024, 7:00 AM EDT - 1 year ago

Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Mar 30, 2024, 1:28 AM EDT - 1 year ago

Xeris Biopharma: Checking-In On One Of My 'Top Ideas'

Mar 6, 2024, 12:43 PM EST - 1 year ago

Xeris Biopharma (XERS) Q4 2023 Earnings Call Transcript

Mar 6, 2024, 7:02 AM EST - 1 year ago

Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events

Mar 6, 2024, 7:00 AM EST - 1 year ago

Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital

Feb 28, 2024, 7:00 AM EST - 1 year ago

Xeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024

Feb 5, 2024, 7:00 AM EST - 1 year ago

Xeris to Present at the Oppenheimer 34th Annual Healthcare Life Science Conference

Jan 10, 2024, 8:00 AM EST - 1 year ago

Xeris Biopharma Enters Into an Exclusive Worldwide License Agreement for Xeriject® Formulation of Teprotumumab

Jan 9, 2024, 1:07 AM EST - 1 year ago

Xeris Biopharma: Speculative Buy, Size Your Position Accordingly

Jan 4, 2024, 7:00 AM EST - 1 year ago

Xeris Biopharma Updates Its Outlook for 2023

Dec 27, 2023, 7:00 AM EST - 1 year ago

Xeris Biopharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Nov 9, 2023, 3:17 PM EST - 1 year ago

Xeris Biopharma Holdings, Inc. (XERS) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 7:00 AM EST - 1 year ago

Xeris Biopharma Reports Third Quarter 2023 Financial Results

Oct 16, 2023, 7:00 AM EDT - 1 year ago

Xeris Biopharma Raises Full-Year Financial Guidance and Reaffirms Cash Flow Breakeven in Q4 2023

Sep 27, 2023, 8:00 AM EDT - 1 year ago

Xeris Biopharma Announces Private Convertible Note Exchange Transactions